Skip to content

COCRYSTAL PHARMA, INC.

COCP

CIK 0001412486

← back to feed
Revenue (TTM)
$2M
−69.3% YoY Q1 May 2026
Net Income (TTM)
−$8.7M
+49.5% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.79
+54.7% YoY Q1 May 2026
Gross Margin
208.4%
Q1 May 2026
Operating Margin
-445.6%
Q1 May 2026
Net Margin
-436.1%
Q1 May 2026
Free Cash Flow (TTM)
−$13.06M
Q1 May 2026
Cash
$7.03M
Q1 May 2026
Total Debt
$50.1M
Q1 May 2026
Shares Outstanding
13.79M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings